Novus (OTC: NDEV) Reports 2025 Year-End Financial Results

About this update from Novus Acquisition & Development Corp.

The company achieved a 14.7% increase in earnings while simultaneously safeguarding shareholder value through effective capital structure management.MIAMI, FL – March 3, 2026 – Novus Acquisition & Development Corp. (OTC: NDEV), the nation's exclusive health insurance provider strategically combining traditional health plans with cannabis integration, today announced its financial results for the fiscal year ended December 31, 2025. The company’s Annual Report reveals consistent revenue expansion, improved liquidity, and a strengthening balance sheet, underscoring the competitive advantage of its resilient, "non-plant-touching" dual-platform model.Fiscal Year 2025 Financial Highlights:Revenue Expansion: Total revenues grew to $404,888 in 2025, up from $368,687 in 2024, representing a 9.8% year-over-year increase.Increased Profitability: Net Income—which also represents the Company's Adjusted Operating Income increased by 14.7%, rising to $195,236 from $170,256 in the previous fiscal year.Strengthened Balance Sheet: Total assets grew to $1,937,132, driven by continued investments in proprietary software and insurance contracts. Cash and cash equivalents improved to $241,912, a 10.7% increase over 2024.Strategic and Corporate Highlights:Industry-Exclusive Integration: Novus is the only health insurance carrier in the United States that integrates cannabis coverage directly with traditional health plans, providing a truly comprehensive approach to patient care.Dual Proprietary Platforms: To ensure strict regulatory compliance and operational efficiency, the Company successfully routes its prescription drug plan and its cannabis benefits through two highly advanced, proprietary platforms that are completely separate.Clean Capital Structure: The Company continues to operate with a highly favorable debt-to-equity profile, maintaining zero outstanding or issued convertible notes.Management Conviction: Reflecting strong internal belief in the Company's long-term trajectory, there have been absolutely zero insider management shares sold over the past three years."Non-Plant-Touching" Resilience: Novus does not cultivate, process, distribute, or sell cannabis. By generating revenue solely from insurance policy receivables, the Company’s business model is completely insulated from supply chain volatility and federal regulatory delays (such as the SAFE Banking Act)...

View stock analysis, news, and events for Novus Acquisition & Development Corp.